BerGenBio ASA
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. BerGenBio ASA's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 9% to $354,000. The net income raised on -$190,401,000 and profit margin reached -53786%. Total operating expenses were $192,173,000.
Profit Margin
| 2014 | 598K | -57.78M | -9662.21% |
|---|---|---|---|
| 2015 | 0 | -72.10M | |
| 2016 | 0 | -129.79M | |
| 2017 | 0 | -182.20M | |
| 2018 | 2.33M | -191.74M | -8211.86% |
| 2019 | 8.9M | -199.38M | -2240.3% |
| 2020 | 601K | -257.06M | -42772.21% |
| 2021 | 774K | -309.41M | -39976.36% |
| 2022 | 389K | -298.60M | -76763.24% |
| 2023 | 354K | -190.40M | -53785.59% |
BGBIO.OL Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 354K | 389K | 774K | 601K | 8.9M | 2.33M | 0 | 0 | 0 | 598K |
Cost of revenue | 0 | 0 | 0 | 89.46M | 65.25M | 0 | 193K | 0 | 179K | 0 |
Gross profit | 354K | 389K | 774K | -88.86M | -56.35M | 2.33M | -193K | 0 | -179K | 598K |
Operating exp. | ||||||||||
Research and development | 107.78M | 8.34M | 12.74M | 21.79M | 21.22M | 10.29M | 12.51M | 17.03M | 4.63M | 5.68M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 192.17M | 306.02M | 315.23M | 261.69M | 213.27M | 196.87M | 183.70M | 131.57M | 72.92M | 59.42M |
Operating income | -191.81M | -305.63M | -314.46M | -261.09M | -204.37M | -194.53M | -183.70M | -131.57M | -72.92M | -58.82M |
Other income (expenses), net | 1.41M | 3.51M | 5.1M | 4.06M | 5.09M | 2.79M | 1.5M | 1.77M | 818K | 1.04M |
Income before tax | -190.40M | -302.12M | -309.36M | -257.02M | -199.27M | -191.74M | -182.20M | -129.79M | -72.10M | -57.78M |
Income tax expense | 0 | -3.51M | 53K | 32K | 109K | 2.83M | 1.53M | 1.79M | 1.07M | 2.30M |
Net income | -190.40M | -298.60M | -309.41M | -257.06M | -199.38M | -191.74M | -182.20M | -129.79M | -72.10M | -57.78M |
Earnings per share | ||||||||||
Basic EPS | -13.3 | -3.37 | -3.04 | -39.37 | -2.97 | -3.06 | -45.19 | -2.22 | -16.35 | -13.11 |
Diluted EPS | -13.3 | -3.37 | -3.04 | -39.37 | -2.97 | -3.06 | -45.19 | -2.22 | -16.35 | -13.11 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |